India · Delayed Price · Currency is INR Nectar Lifesciences Statistics
Total Valuation
NSE:NECLIFE has a market cap or net worth of INR 2.23 billion. The enterprise value is 982.95 million.
| Market Cap | 2.23B |
| Enterprise Value | 982.95M |
Important Dates
The last earnings date was Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:NECLIFE has 194.26 million shares outstanding. The number of shares has decreased by -5.35% in one year.
| Current Share Class | 194.26M |
| Shares Outstanding | 194.26M |
| Shares Change (YoY) | -5.35% |
| Shares Change (QoQ) | -3.01% |
| Owned by Insiders (%) | 56.26% |
| Owned by Institutions (%) | 5.30% |
| Float | 84.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15,406.90 |
| PB Ratio | 0.38 |
| P/TBV Ratio | 0.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.10 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -16.70% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 7.82% |
| Revenue Per Employee | 1,306 |
| Profits Per Employee | -22.08M |
| Employee Count | 111 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -394.80M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.65% in the last 52 weeks. The beta is 0.65, so NSE:NECLIFE's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | -18.65% |
| 50-Day Moving Average | 11.14 |
| 200-Day Moving Average | 13.24 |
| Relative Strength Index (RSI) | 48.04 |
| Average Volume (20 Days) | 342,758 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:NECLIFE had revenue of INR 145,000 and -2.45 billion in losses. Loss per share was -11.60.
| Revenue | 145,000 |
| Gross Profit | 8,000 |
| Operating Income | -763.52M |
| Pretax Income | -1.13B |
| Net Income | -2.45B |
| EBITDA | -634.45M |
| EBIT | -763.52M |
| Loss Per Share | -11.60 |
Balance Sheet
The company has 1.25 billion in cash and no debt, with a net cash position of 1.25 billion or 6.44 per share.
| Cash & Cash Equivalents | 1.25B |
| Total Debt | n/a |
| Net Cash | 1.25B |
| Net Cash Per Share | 6.44 |
| Equity (Book Value) | 5.82B |
| Book Value Per Share | 28.98 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was -3.49 billion and capital expenditures -122.74 million, giving a free cash flow of -3.61 billion.
| Operating Cash Flow | -3.49B |
| Capital Expenditures | -122.74M |
| Depreciation & Amortization | 129.07M |
| Net Borrowing | -6.49B |
| Free Cash Flow | -3.61B |
| FCF Per Share | -18.58 |
Margins
| Gross Margin | 5.52% |
| Operating Margin | -526,564.14% |
| Pretax Margin | -776,784.83% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NSE:NECLIFE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.35% |
| Shareholder Yield | 5.35% |
| Earnings Yield | -109.69% |
| FCF Yield | -161.59% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 12, 2008. It was a forward split with a ratio of 10.
| Last Split Date | Nov 12, 2008 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |